• Study of MK-2214 to slow disease progression in people with early Alzheimer’s disease

    Recruiting

    2 1
    Investigated Drugs:
    Belgium The Netherlands Spain
  • Testing the safety of stopping riociguat in patients with chronic thromboembolic pulmonary hypertension after successful balloon pulmonary angioplasty treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of sublingual immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinae allergen mix for patients with dust mite allergic rhinitis

    Recruiting

    2 1
    Investigated Diseases:
    Spain
  • Study of gene-modified stem cells (FT024) in children with TCIRG1-related osteopetrosis using treosulfan, thiotepa, and plerixafor for treatment

    Recruiting

    2 1 1 1
    Italy
  • Study of Mitazalimab Injection Treatment for Patients with High-Risk Oral Potentially Malignant Disorders

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Long-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of Ritlecitinib Combined with Narrow Band UVB Light Therapy Compared to Ritlecitinib Alone in Adults with Vitiligo

    Recruiting

    2 1 1 1
    France
  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Recruiting

    3 1 1
    Investigated Drugs:
    Italy
  • Evaluating intraperitoneal irinotecan with systemic therapy in patients with gastric peritoneal metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Comparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Sweden

powered by